Skip to content

HYPR

Hyperfine, Inc.

NASDAQ · Healthcare · Medical - Devices · US

$0.81
−2.83%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue16.5M13.6M12.9M11.0M6.8M
Cost of Revenue8.0M6.8M7.0M6.3M5.9M
Gross Profit8.5M6.8M5.9M4.8M907.0K
Operating Expenses
R&D Expense15.6M17.5M22.5M22.5M28.2M
SG&A Expense26.5M26.4M26.6M30.4M46.6M
General & Admin Expense16.2M16.3M17.5M20.3M32.4M
Selling & Marketing Expense10.3M10.1M9.1M10.1M14.2M
Other Expenses
Total Operating Expenses42.1M43.8M49.1M52.9M74.8M
Cost and Expenses50.2M50.6M56.1M59.1M80.7M
Operating Income (EBIT)(33.6M)(37.1M)(43.2M)(48.1M)(73.9M)
Non-Operating
Interest Income993.0K1.0M2.5M3.8M761.0K
Interest Expense616.0K
Net Interest Income377.0K1.0M2.5M3.8M761.0K
Other Non-Op Income/Expense(1.2M)1.5M2.5M3.9M710.0K
Non-Operating Income (excl Interest)621.0K(1.5M)(2.5M)(3.9M)(710.0K)
EBT (Pre-Tax Income)(34.9M)(35.6M)(40.7M)(44.2M)(73.2M)
Income Tax Expense
Bottom Line
Net Income(34.9M)(35.6M)(40.7M)(44.2M)(73.2M)
Earnings from Cont. Ops(34.9M)(35.6M)(40.7M)(44.2M)(73.2M)
Earnings from Discont. Ops
Bottom Line Net Income(34.9M)(35.6M)(40.7M)(44.2M)(73.2M)
Per Share
Basic EPS($0.38)($0.43)($0.56)($0.62)($1.04)
Diluted EPS($0.38)($0.43)($0.56)($0.62)($1.04)
Revenue Per Share$0.17$0.14$0.18$0.15$0.10
Shares
Basic Shares Outstanding99.8M94.2M72.4M71.3M70.4M
Diluted Shares Outstanding99.8M94.2M72.4M71.3M70.4M
Profitability Metrics
EBITDA(32.4M)(33.4M)(39.7M)(43.2M)(72.1M)
D&A1.8M2.2M1.0M1.1M1.0M
EBIT(34.2M)(35.6M)(40.7M)(44.2M)(73.2M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026